Adverse effects of biologics: a network meta-analysis and Cochrane overview

  • Protocol
  • Overview

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective is to assess the adverse effects of nine biologics: abatacept, adalimumab, anakinra, certolizumab, etanercept, golimumab, infliximab, rituximab and tocilizumab, across different indications of use.

Ancillary